News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,164 Results
Type
Article (42165)
Company Profile (295)
Press Release (669704)
Section
Business (210297)
Career Advice (2090)
Deals (36615)
Drug Delivery (105)
Drug Development (82951)
Employer Resources (172)
FDA (16531)
Job Trends (15381)
News (355741)
Policy (33858)
Tag
Academia (2579)
Alliances (51317)
Alzheimer's disease (1332)
Approvals (16512)
Artificial intelligence (214)
Bankruptcy (367)
Best Places to Work (11771)
Biotechnology (189)
Breast cancer (228)
Cancer (1741)
Cardiovascular disease (135)
Career advice (1747)
Cell therapy (357)
Clinical research (66792)
Collaboration (677)
Compensation (375)
COVID-19 (2634)
C-suite (163)
Data (1640)
Diabetes (214)
Diagnostics (6367)
Earnings (87127)
Employer resources (149)
Events (113726)
Executive appointments (577)
FDA (17448)
Funding (611)
Gene therapy (259)
GLP-1 (684)
Government (4478)
Healthcare (18949)
Infectious disease (2746)
Inflammatory bowel disease (124)
Interviews (321)
IPO (16737)
Job creations (4054)
Job search strategy (1491)
Layoffs (460)
Legal (8353)
Lung cancer (257)
Manufacturing (245)
Medical device (13347)
Medtech (13352)
Mergers & acquisitions (20245)
Metabolic disorders (568)
Neuroscience (1750)
NextGen: Class of 2025 (6635)
Non-profit (4523)
Northern California (2100)
Obesity (318)
Opinion (218)
Patents (166)
People (58797)
Phase I (20708)
Phase II (29401)
Phase III (22017)
Pipeline (717)
Postmarket research (2653)
Preclinical (8760)
Radiopharmaceuticals (246)
Rare diseases (336)
Real estate (6248)
Regulatory (22775)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1801)
Startups (3717)
United States (18646)
Vaccines (631)
Weight loss (224)
Date
Today (90)
Last 7 days (604)
Last 30 days (2665)
Last 365 days (35014)
2025 (4502)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56330)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32517)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (779)
Arizona (218)
Asia (40385)
Australia (6469)
California (4794)
Canada (1723)
China (402)
Colorado (220)
Connecticut (231)
Europe (86059)
Florida (691)
Georgia (165)
Illinois (466)
Indiana (268)
Japan (125)
Maryland (747)
Massachusetts (3660)
Michigan (200)
Minnesota (336)
New Jersey (1362)
New York (1366)
North Carolina (852)
Northern California (2100)
Ohio (173)
Pennsylvania (1103)
South America (1159)
Southern California (1801)
Texas (711)
Utah (143)
Washington State (474)
712,164 Results for "ultragenyx pharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
February 14, 2025
·
15 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 19, 2025
February 19, 2025
·
1 min read
Press Releases
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update
February 6, 2025
·
1 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025
·
1 min read
Press Releases
Ultragenyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Ultragenyx to Participate in Investor Conferences in December
November 26, 2024
·
1 min read
Biotech Bay
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 20, 2024
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, reported the grant of 45,525 restricted stock units of the company’s common stock to 26 newly hired non-executive officers of the company.
June 20, 2024
·
1 min read
Biotech Bay
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - June 12, 2024
Ultragenyx Pharmaceutical Inc. announced that it has commenced an underwritten public offering of up to $350,000,000 of shares of its common stock and, in lieu of issuing common stock to certain investors, pre-funded warrants to purchase shares of its common stock.
June 12, 2024
·
4 min read
Biotech Bay
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 17, 2024
Ultragenyx Pharmaceutical Inc. reported the grant of 17,180 restricted stock units of the company’s common stock to ten newly hired non-executive officers of the company.
May 17, 2024
·
1 min read
Press Releases
Ultragenyx Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
February 19, 2025
·
6 min read
1 of 71,217
Next
